Kyle Mikson
Stock Analyst at Canaccord Genuity
(0.44)
# 3,100
Out of 4,435 analysts
49
Total ratings
15.91%
Success rate
-32.9%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKYA Akoya Biosciences | Maintains: Buy | $10 → $6 | $2.15 | +179.07% | 2 | May 14, 2024 | |
| NTRA Natera | Maintains: Buy | $100 → $130 | $106.53 | +22.03% | 2 | May 10, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $90 → $85 | $45.45 | +87.02% | 6 | May 9, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $65 → $50 | $22.42 | +123.02% | 4 | Apr 29, 2024 | |
| TTOO T2 Biosystems | Maintains: Hold | $12 → $3 | $5.14 | -41.63% | 2 | Apr 29, 2024 | |
| QTRX Quanterix | Maintains: Buy | $32 → $25 | $15.97 | +56.54% | 4 | Apr 29, 2024 | |
| GH Guardant Health | Maintains: Buy | $45 → $30 | $27.10 | +10.70% | 3 | Apr 29, 2024 | |
| OLK Olink Holding AB (publ) | Reiterates: Hold | $26 | $23.95 | +8.56% | 2 | Mar 26, 2024 | |
| BDSX Biodesix | Reiterates: Buy | $3.5 | $1.43 | +144.76% | 2 | Mar 4, 2024 | |
| ILMN Illumina | Downgrades: Hold | $210 → $120 | $104.28 | +15.07% | 5 | Nov 10, 2023 | |
| PACB Pacific Biosciences of California | Maintains: Buy | $17 → $15 | $1.79 | +737.99% | 5 | Oct 31, 2023 | |
| QSI Quantum-Si incorporated | Downgrades: Hold | $3.5 → $2 | $1.52 | +31.58% | 2 | Sep 25, 2023 | |
| VNRX VolitionRx | Maintains: Overweight | $3 → $2 | $0.71 | +183.41% | 2 | Aug 16, 2023 | |
| CSTL Castle Biosciences | Maintains: Buy | $60 → $40 | $23.26 | +71.97% | 2 | Jun 6, 2023 | |
| XGN Exagen | Maintains: Buy | $8 → $7 | $1.95 | +258.97% | 1 | Nov 15, 2022 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $18 → $12 | $0.89 | +1,247.56% | 2 | Mar 29, 2022 | |
| PAVM PAVmed | Initiates: Overweight | $49 | $1.45 | +3,293.10% | 1 | Mar 30, 2021 | |
| ICAD iCAD, Inc. | Initiates: Overweight | n/a | $1.45 | - | 1 | Jan 29, 2021 | |
| AWH Aspira Women's Health | Initiates: Overweight | n/a | $2.47 | - | 1 | Jan 29, 2021 |
Akoya Biosciences
May 14, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $2.15
Upside: +179.07%
Natera
May 10, 2024
Maintains: Buy
Price Target: $100 → $130
Current: $106.53
Upside: +22.03%
Exact Sciences
May 9, 2024
Maintains: Buy
Price Target: $90 → $85
Current: $45.45
Upside: +87.02%
10x Genomics
Apr 29, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $22.42
Upside: +123.02%
T2 Biosystems
Apr 29, 2024
Maintains: Hold
Price Target: $12 → $3
Current: $5.14
Upside: -41.63%
Quanterix
Apr 29, 2024
Maintains: Buy
Price Target: $32 → $25
Current: $15.97
Upside: +56.54%
Guardant Health
Apr 29, 2024
Maintains: Buy
Price Target: $45 → $30
Current: $27.10
Upside: +10.70%
Olink Holding AB (publ)
Mar 26, 2024
Reiterates: Hold
Price Target: $26
Current: $23.95
Upside: +8.56%
Biodesix
Mar 4, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.43
Upside: +144.76%
Illumina
Nov 10, 2023
Downgrades: Hold
Price Target: $210 → $120
Current: $104.28
Upside: +15.07%
Pacific Biosciences of California
Oct 31, 2023
Maintains: Buy
Price Target: $17 → $15
Current: $1.79
Upside: +737.99%
Quantum-Si incorporated
Sep 25, 2023
Downgrades: Hold
Price Target: $3.5 → $2
Current: $1.52
Upside: +31.58%
VolitionRx
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.71
Upside: +183.41%
Castle Biosciences
Jun 6, 2023
Maintains: Buy
Price Target: $60 → $40
Current: $23.26
Upside: +71.97%
Exagen
Nov 15, 2022
Maintains: Buy
Price Target: $8 → $7
Current: $1.95
Upside: +258.97%
Lucid Diagnostics
Mar 29, 2022
Maintains: Buy
Price Target: $18 → $12
Current: $0.89
Upside: +1,247.56%
PAVmed
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $1.45
Upside: +3,293.10%
iCAD, Inc.
Jan 29, 2021
Initiates: Overweight
Price Target: n/a
Current: $1.45
Upside: -
Aspira Women's Health
Jan 29, 2021
Initiates: Overweight
Price Target: n/a
Current: $2.47
Upside: -